TP53 and posterior cortical atrophy: In 2018, Maughan and coworkers showed that p53 status in the primary PCa is predictive of inferior response to AR signaling inhibitors in mCRPC[73], suggesting that p53 loss-associated metabolic alterations might be involved in the acquisition of resistance to AR signaling inhibitors.